article_metadata: Marjorie Faure Philippe Rochigneux Daniel Olive Sébastien Taix Isabelle Brenot-Rossi Marine Gilabert
article_metadata: 10.3389/fimmu.2018.00797
article_metadata: Front Immunol
article_metadata: 2018 Apr 19;9:797.
article_metadata: anti-pd1 hyperprogression immune checkpoint inhibitors immunomonitoring melanoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/29725330/
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antineoplastic Agents, Immunological / adverse effects Melanoma / drug therapy Melanoma / pathology Rectal Neoplasms / drug therapy Rectal Neoplasms / pathology
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antineoplastic Agents, Immunological / adverse effects Melanoma / drug therapy Melanoma / pathology Rectal Neoplasms / drug therapy Rectal Neoplasms / pathology Case Reports Research Support, Non-U.S. Gov't Aged Disease Progression Fatal Outcome Humans Male Melanoma / immunology Neoplasm Recurrence, Local / drug therapy Neoplasm Recurrence, Local / immunology Neoplasm Recurrence, Local / pathology Rectal Neoplasms / immunology Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological pembrolizumab
article_metadata: PMC5916968
article_metadata: 29725330
article_metadata: Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
article_metadata: 2018